GlassScriptPhysician profile
Anna M Widmyer
NPI 1346477163
$3,502.29
in general payments reported to CMS, 2019-2025
22 companies · $1,110 in 2025
The $1,110 reported for 2025 was more than what 75% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $298 · 2021: $63.93 · 2022: $625 · 2023: $230 · 2024: $565 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,170.76 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $502.42 | 2023-2025 | |
| Integra Lifesciences Corporation | $370.76 | 2023-2025 | Integra, Omnigraft, Surgimend |
| Sientra, INC. | $316.05 | 2022 | |
| Tepha INC | $278.19 | 2019-2020 | |
| Allergan, INC. | $203.27 | 2019-2022 | |
| Acera Surgical, INC. | $133.74 | 2025 | Restrata Wound Matrix |
| Bard Peripheral Vascular, INC. | $108.46 | 2020 | |
| Tela Bio, INC. | $55.41 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Revance Therapeutics, INC. | $46.47 | 2024 | Daxxify |
| Aroa Biosurgery Incorporated | $40.66 | 2022 | |
| Innovation Technologies INC | $39.98 | 2025 | Irrisept |
| Merz North America, INC. | $38.20 | 2024 | |
| Baxter Healthcare | $35.66 | 2023 | Artiss |
| Ethicon US, LLC | $32.68 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $29.96 | 2020 | |
| Avanos Medical | $22.22 | 2019 | |
| Stryker Corporation | $19.43 | 2019 | |
| Smith+Nephew, INC. | $15.94 | 2020 | |
| Solventum Corporation | $15.69 | 2024 | Prevena |
| Kci USA, INC. | $14.77 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Widmyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.